Aspergillus fumigatus and related species

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 2, 2015, Pages

  Sugui, Janyce A ^a   Kwon Chung, Kyung J ^a   Juvvadi, Praveen R ^b   Latgé, Jean Paul ^c   Steinbach, William J ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VORICONAZOLE;

ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; EARLY DIAGNOSIS; ECOLOGY; FUNGAL VIRULENCE; HUMAN; IMMUNE SYSTEM; INVASIVE ASPERGILLOSIS; META ANALYSIS; MYCOLOGY; NONHUMAN; SPECIES IDENTIFICATION; CLASSIFICATION; INVASIVE PULMONARY ASPERGILLOSIS; PATHOGENICITY;

ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; EMERICELLA NIDULANS;

ASPERGILLUS FUMIGATUS; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS;

EID: 84923786469     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a019786     Document Type: Article

References (150)

1. Abad A, Fernandez-Molina JV, Bikandi J, Ramirez A, Mar-gareto J, Sendino J, Hernando FL, Ponton J, Garaizar J, Rementeria A. 2010. What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Rev Iberoam Micol 27: 155-182.
2. Aimanianda V, Bayry J, Bozza S, Kniemeyer O, Perruccio K, Elluru SR, Clavaud C, Paris S, Brakhage AA, Kaveri SV, et al. 2009. Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 460: 1117-1121.
3. Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL. 2008. Aspergillus section Fumigati: Antifungal susceptibility patterns and se-quence-based identification. Antimicrob Agents Chemo-ther 52: 1244-1251.
4. Alekseeva L, Huet D, Femenia F, Mouyna I, Abdelouahab M, Cagna A, Guerrier D, Tichanne-Seltzer V, Baeza-Squiban A, Chermette R, et al. 2009. Inducible expression of b defensins by human respiratory epithelial cells exposed to Aspergillus fumigatus organisms. BMC Microbiol 9: 33.
5. Alhambra A, Catalan M, Moragues MD, Brena S, Ponton J, Montejo JC, del Palacio A. 2008. Isolation of Aspergillus lentulus in Spain from a critically ill patient with chronic obstructive pulmonary disease. Rev Iberoam Micol 25: 246-249.
6. Askew DS. 2008. Aspergillus fumigatus: Virulence genes in a street-smart mold. Curr Opin Microbiol 11: 331-337.
7. Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alex-ander BD, Kauffman CA, Oster RA, Anaissie EJ, Walsh TJ, Schuster MG, et al. 2010. Factors associated with mortal-ity in transplant patients with invasive aspergillosis. Clin Infect Dis 50: 1559-1567.
8. Balajee SA, Nickle D, Varga J, Marr KA. 2006. Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping. Eukaryot Cell 5: 1705-1712.
9. Barrs VR, van Doorn TM, Houbraken J, Kidd SE, Martin P, Pinheiro MD, Richardson M, Varga J, Samson RA. 2013. Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs. PLoS ONE 8: e64871
10. Bayry J, Aimanianda V, Guijarro JI, Sunde M, Latgé JP. 2012. Hydrophobins—Unique fungal proteins. PLoS Pathog 8: e1002700.
11. Bhabhra R, Miley MD, Mylonakis E, Boettner D, Fortwendel J, Panepinto JC, Postow M, Rhodes JC, Askew DS. 2004. Disruption of the Aspergillus fumigatus gene encoding nucleolar protein CgrA impairs thermotolerant growth and reduces virulence. Infect Immun 72: 4731-4740.
12. Bok JW, Balajee SA, Marr KA, Andes D, Nielsen KF, Frisvad JC, Keller NP. 2005. LaeA, a regulator of morphogenetic fungal virulence factors. Eukaryot Cell 4: 1574-1582.
13. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. 2012. Hidden killers: Human fungal infec-tions. Sci Transl Med 4: 165rv113.
14. Bruns S, Kniemeyer O, Hasenberg M, Aimanianda V, Nietzsche S, Thywissen A, Jeron A, Latgé JP, Brakhage AA, Gunzer M. 2010. Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influ-enced by hydrophobin RodA. PLoS Pathog 6: e1000873.
15. Caputo R. 2003. Itraconazole (Sporanox) in superficial and systemic fungal infections. Expert Rev Anti Infect Ther 1: 531-542.
16. Cohen MS, Isturiz RE, Malech HL, Root RK, Wilfert CM, Gutman L, Buckley RH. 1981. Fungal infection in chron-ic granulomatous disease. The importance of the phago-cyte in defense against fungi. Am J Med 71: 59-66
17. Cohen J, Postma DS, Douma WR, Vonk JM, De Boer AH, ten Hacken NH. 2011. Particle size matters: Diagnostics and treatment of small airways involvement in asthma. Eur Respir J 37: 532-540.
18. Conway SP, Etherington C, Peckham DG, Brownlee KG, Whitehead A, Cunliffe H. 2004. Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis. J Antimicrob Chemother 53: 841-847.
19. Coriglione G, Stella G, Gafa L, Spata G, Oliveri S, Padhye AA, Ajello L. 1990. Neosartorya fischeri var fischeri (Wehmer) Malloch and Cain 1972 (Anamorph: Aspergil-lus fischerianus Samson and Gams 1985) as a cause of mycotic keratitis. Eur J Epidemiol 6: 382-385.
20. Cramer RA Jr, Gamcsik MP, Brooking RM, Najvar LK, Kirk-patrick WR, Patterson TF, Balibar CJ, Graybill JR, Perfect JR, Abraham SN, et al. 2006. Disruption of a nonriboso-mal peptide synthetase in Aspergillus fumigatus elimi-nates gliotoxin production. Eukaryot Cell 5: 972-980.
21. Cramer RA Jr, Perfect BZ, Pinchai N, Park S, Perlin DS, Asfaw YG, Heitman J, Perfect JR, Steinbach WJ. 2008. Calcineurin target CrzA regulates conidial germination, hyphal growth, and pathogenesis of Aspergillus fumiga-tus. Eukaryot Cell 7: 1085-1097.
22. Dagenais TR, Keller NP. 2009. Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clin Microbiol Rev 22: 447-465.
23. da Silva Ferreira ME, Heinekamp T, Hartl A, Brakhage AA, Semighini CP, Harris SD, Savoldi M, de Gouvea PF, de Souza Goldman MH, Goldman GH. 2007. Functional characterization of the Aspergillus fumigatus calcineurin. Fungal Genet Biol 44: 219-230.
24. Denning DW. 1998. Invasive aspergillosis. Clin Infect Dis 26: 781-803.
25. Denning DW, Evans EG, Kibbler CC, Richardson MD, Rob-erts MM, Rogers TR, Warnock DW, Warren RE. 1997. Guidelines for the investigation of invasive fungal infec-tions in haematological malignancy and solid organ transplantation. Eur J Clin Microbiol Infect Dis 16: 424-436.
26. Dinamarco TM, Almeida RS, de Castro PA, Brown NA, dos Reis TF, Ramalho LN, Savoldi M, Goldman MH, Gold-man GH. 2012. Molecular characterization of the puta-tive transcription factor SebA involved in virulence in Aspergillus fumigatus. Eukaryot Cell 11: 518-531.
27. Ejzykowicz DE, Cunha MM, Rozental S, Solis NV, Gravelat FN, Sheppard DC, Filler SG. 2009. The Aspergillus fumi-gatus transcription factor Ace2 governs pigment produc-tion, conidiation and virulence. Mol Microbiol 72: 155-169.
28. Ejzykowicz DE, Solis NV, Gravelat FN, Chabot J, Li X, Shep-pard DC, Filler SG. 2010. Role of Aspergillus fumigates DvrA in host cell interactions and virulence. Eukaryot Cell 9: 1432-1440.
29. Espinel-Ingroff A, Diekema DJ, Fothergill A, Johnson E, Pelaez T, Pfaller MA, Rinaldi MG, Canton E, Turnidge J. 2010. Wild-type MIC distributions and epidemiologi-cal cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). J Clin Microbiol 48: 3251-3257.
30. Espinel-Ingroff A, Cuenca-Estrella M, Fothergill A, Fuller J, Ghannoum M, Johnson E, Pelaez T, Pfaller MA, Turnidge J. 2011. Wild-type MIC distributions and epidemiologi-cal cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob Agents Chemother 55: 5150-5154.
31. Feng X, Krishnan K, Richie DL, Aimanianda V, Hartl L, Grahl N, Powers-Fletcher MV, Zhang M, Fuller KK, Nier-man WC, et al. 2011. HacA-independent functions of the ER stress sensor IreA synergize with the canonical UPR to influence virulence traits in Aspergillus fumigatus. PLoS Pathog 7: e1002330.
32. Fortwendel JR, Zhao W, Bhabhra R, Park S, Perlin DS, Askew DS, Rhodes JC. 2005. A fungus-specific Ras homolog contributes to the hyphal growth and virulence of Asper-gillus fumigatus. Eukaryot Cell 4: 1982-1989.
33. Fortwendel JR, Juvvadi PR, Rogg LE, Asfaw YG, Burns KA, Randell SH, Steinbach WJ. 2012. Plasma membrane lo-calization is required for RasA-mediated polarized mor-phogenesis and virulence of Aspergillus fumigatus. Eukaryot Cell 11: 966-977.
34. Fresenius G. 1863. Beiträge zur Mykologie. H.L. Bronner, Frankfurt.
35. Gams W, Christensen M, Onions AH, Pitt JI, Samson RA. 1985. Infrageneric taxa of Aspergillus. In Advances in penicillium and Aspergillus systematics (ed. Samson RA, Pitt J), pp. 55-62. Plenum, New York.
36. Ghebremedhin B, Bluemel A, Neumann KH, Koenig B, Koe-nig W. 2009. Peritonitis due to Neosartorya pseudofischeri in an elderly patient undergoing peritoneal dialysis suc-cessfully treated with voriconazole. J Med Microbiol 58: 678-682.
37. Girmenia C, Nucci M, Martino P. 2001. Clinical significance of Aspergillus fungaemia in patients with haematological malignancies and invasive aspergillosis. Br J Haematol 114: 93-98.
38. Grahl N, Dinamarco TM, Willger SD, Goldman GH, Cramer RA. 2012. Aspergillus fumigatus mitochondrial electron transport chain mediates oxidative stress ho-meostasis, hypoxia responses and fungal pathogenesis. Mol Microbiol 84: 383-399.
39. Gravelat FN, Ejzykowicz DE, Chiang LY, Chabot JC, Urb M, Macdonald KD, al-Bader N, Filler SG, Sheppard DC. 2010. Aspergillus fumigatus MedA governs adherence, host cell interactions and virulence. Cell Microbiol 12: 473-488.
40. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. 1996. Trends in the postmortem epidemi-ology of invasive fungal infections at a university hospi-tal. J Infect 33: 23-32.
41. Guarro J, Kallas EG, Godoy P, Karenina A, Gene J, Stchigel A, Colombo AL. 2002. Cerebral aspergillosis caused by Neo-sartorya hiratsukae, Brazil. Emerg Infect Dis 8: 989-991.
42. Gyotoku H, Izumikawa K, Ikeda H, Takazono T, Morinaga Y, Nakamura S, Imamura Y, Nishino T, Miyazaki T, Kakeya H, et al. 2012. A case of bronchial aspergillosis caused by Aspergillus udagawae and its mycological features. Med Mycol 50: 631-636.
43. Haas H. 2012. Iron—A key nexus in the virulence of Asper-gillus fumigatus. Front Microbiol 3: 28.
44. Hawksworth DL, Crous PW, Redhead SA, Reynolds DR, Samson RA, Seifert KA, Taylor JW, Wingfield MJ, Abaci O, Aime C, et al. 2011. The Amsterdam declaration on fungal nomenclature. IMA Fungus 2: 105-112.
45. Heinekamp T, Thywissen A, Macheleidt J, Keller S, Valiante V, Brakhage AA. 2013. Aspergillus fumigatus melanins: Interference with the host endocytosis pathway and im-pact on virulence. Front Microbiol 3: 440.
46. Henriet S, Verweij PE, Holland SM, Warris A. 2013. Invasive fungal infections in patients with chronic granulomatous disease. Adv Exp Med Biol 764: 27-55.
47. Hensel M, Arst HN Jr, Aufauvre-Brown A, Holden DW. 1998. The role of the Aspergillus fumigatus areA gene in invasive pulmonary aspergillosis. Mol Gen Genet 258: 553-557.
48. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortho-lary O, et al. 2002. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347: 408-415.
49. Hissen AH, Wan AN, Warwas ML, Pinto LJ, Moore MM. 2005. The Aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-ornithine N5-oxygenase, is re-quired for virulence. Infect Immun 73: 5493-5503.
50. Ho PL, Yuen KY. 2000. Aspergillosis in bone marrow trans-plant recipients. Crit Rev Oncol Hematol 34: 55-69.
51. Hohl TM, Feldmesser M. 2007. Aspergillus fumigatus: Prin-ciples of pathogenesis and host defense. Eukaryot Cell 6: 1953-1963.
52. Horn BW, Moore GG, Carbone I. 2009. Sexual reproduction in Aspergillus flavus. Mycologia 101: 423-429.
53. Houbraken J, Samson RA. 2011. Phylogeny of Penicillium and the segregation of Trichocomaceae into three families. Stud Mycol 70: 1-51.
54. Ibrahim-Granet O, Philippe B, Boleti H, Boisvieux-Ulrich E, Grenet D, Stern M, Latgé JP. 2003. Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alve-olar macrophages. Infect Immun 71: 891-903.
55. Ibrahim-Granet O, Dubourdeau M, Latgé JP, Ave P, Huerre M, Brakhage AA, Brock M. 2008. Methylcitrate synthase from Aspergillus fumigatus is essential for manifestation of invasive aspergillosis. Cell Microbiol 10: 134-148.
56. Jantunen E, Ruutu P, Piilonen A, Volin L, Parkkali T, Ruutu T. 2000. Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 26: 759-762.
57. Jarv H, Lehtmaa J, Summerbell RC, Hoekstra ES, Samson RA, Naaber P. 2004. Isolation of Neosartorya pseudofi-scheri from blood: First hint of pulmonary aspergillosis. J Clin Microbiol 42: 925-928.
58. Jensen HL. 1931. The fungus flora of the soil. Soil Sci 31: 123-158.
59. Kawazu M, Kanda Y, Nannya Y, Aoki K, Kurokawa M, Chiba S, Motokura T, Hirai H, Ogawa S. 2004. Prospective com-parison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1!3)-b-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 42: 2733-2741.
60. Kontoyiannis DP, Bodey GP. 2002. Invasive aspergillosis in 2002: An update. Eur J Clin Microbiol Infect Dis 21: 161-172.
61. Kozakiewicz Z, Smith D. 1994. Physiology of Aspergillus. In Biotechnology handbooks: Aspergillus (ed. Smith JE), pp. 23-38. Plenum, New York.
62. Krappmann S, Bignell EM, Reichard U, Rogers T, Haynes K, Braus GH. 2004. The Aspergillus fumigatus transcription-al activator CpcA contributes significantly to the viru-lence of this fungal pathogen. Mol Microbiol 52: 785-799.
63. Kupfahl C, Heinekamp T, Geginat G, Ruppert T, Hartl A, Hof H, Brakhage AA. 2006. Deletion of the gliP gene of Aspergillus fumigatus results in loss of gliotoxin produc-tion but has no effect on virulence of the fungus in a low-dose mouse infection model. Mol Microbiol 62: 292-302.
64. Kwon-Chung KJ, Bennett JE. 1992. Medical mycology. Lea & Febiger, Philadelphia.
65. Kwon-Chung J, Sugui JA. 2013. Aspergillus fumigatus— What makes the species a ubiquitous human fungal path-ogen? PLoS Pathog 9: e1003743.
66. Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, Richardson M, Marchetti O. 2012. b-Glucan antige-nemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: A system-atic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis 54: 633-643.
67. Langfelder K, Jahn B, Gehringer H, Schmidt A, Wanner G, Brakhage AA. 1998. Identification of a polyketide syn-thase gene (pksP) of Aspergillus fumigatus involved in conidial pigment biosynthesis and virulence. Med Micro-biol Immunol 187: 79-89.
68. Latgé JP. 1999. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12: 310-350.
69. Lessing F, Kniemeyer O, Wozniok I, Loeffler J, Kurzai O, Haertl A, Brakhage AA. 2007. The Aspergillus fumigates transcriptional regulator AfYap1 represents the major regulator for defense against reactive oxygen intermedi-ates but is dispensable for pathogenicity in an intranasal mouse infection model. Eukaryot Cell 6: 2290-2302.
70. Li H, Zhou H, Luo Y, Ouyang H, Hu H, Jin C. 2007. Gly-cosylphosphatidylinositol (GPI) anchor is required in Aspergillus fumigatus for morphogenesis and virulence. Mol Microbiol 64: 1014-1027.
71. Liebmann B, Muller M, Braun A, Brakhage AA. 2004. The cyclic AMP-dependent protein kinase a network regu-lates development and virulence in Aspergillus fumigatus. Infect Immun 72: 5193-5203.
72. Lin SJ, Schranz J, Teutsch SM. 2001. Aspergillosis case-fatal-ity rate: Systematic review of the literature. Clin Infect Dis 32: 358-366.
73. Liu H, Gravelat FN, Chiang LY, Chen D, Vanier G, Ejzyko-wicz DE, Ibrahim AS, Nierman WC, Sheppard DC, Filler SG. 2010. Aspergillus fumigatus AcuM regulates both iron acquisition and gluconeogenesis. Mol Microbiol 78: 1038-1054.
74. Lonial S, Williams L, Carrum G, Ostrowski M, McCarthy P Jr 1997. Neosartorya fischeri: An invasive fungal pathogen in an allogeneic bone marrow transplant patient. Bone Marrow Transplant 19: 753-755.
75. Lortholary O, Gangneux JP, Sitbon K, Lebeau B, de Mon-brison F, Le Strat Y, Coignard B, Dromer F, Bretagne S. 2011. Epidemiological trends in invasive aspergillosis in France: The SAIF network (2005-2007). Clin Microbiol Infect 17: 1882-1889.
76. Ma YJ, Doni A, Romani L, Jurgensen HJ, Behrendt N, Man-tovani A, Garred P. 2013. Ficolin-1-PTX3 complex for-mation promotes clearance of altered self-cells and mod-ulates IL-8 production. J Immunol 191: 1324-1333.
77. Madan T, Reid KB, Clark H, Singh M, Nayak A, Sarma PU, Hawgood S, Kishore U. 2010. Susceptibility of mice ge-netically deficient in SP-A or SP-D gene to invasive pul-monary aspergillosis. Mol Immunol 47: 1923-1930.
78. Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenberghe P, Van Eldere J, Verbist L, Boogaerts M. 1999. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol 37: 3223-3228.
79. Malejczyk K, Sigler L, Gibas CF, Smith SW. 2013. Invasive sino-orbital mycosis in an aplastic anemia patient caused by Neosartorya laciniosa. J Clin Microbiol 51: 1316-1319.
80. Marr KA, Carter RA, Crippa F, Wald A, Corey L. 2002a. Epidemiology and outcome of mould infections in he-matopoietic stem cell transplant recipients. Clin Infect Dis 34: 909-917.
81. Marr KA, Patterson T, Denning D. 2002b. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 16: 875-894.
82. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. 2004. Detection of galactomannan antige-nemia by enzyme immunoassay for the diagnosis of in-vasive aspergillosis: Variables that affect performance. J Infect Dis 190: 641-649.
83. Maubon D, Park S, Tanguy M, Huerre M, Schmitt C, Prevost MC, Perlin DS, Latgé JP, Beauvais A. 2006. AGS3, an a(1-3)glucan synthase gene family member of Aspergil-lus fumigatus, modulates mycelium growth in the lung of experimentally infected mice. Fungal Genet Biol 43: 366-375.
84. McCormick A, Heesemann L, Wagener J, Marcos V, Hartl D, Loeffler J, Heesemann J, Ebel F. 2010. NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus. Microbes Infect 12: 928-936.
85. McDonagh A, Fedorova ND, Crabtree J, Yu Y, Kim S, Chen D, Loss O, Cairns T, Goldman G, Armstrong-James D, et al. 2008. Sub-telomere directed gene expression during initiation of invasive aspergillosis. PLoS Pathog 4: e1000154.
86. Mellado E, Aufauvre-Brown A, Gow NA, Holden DW. 1996. The Aspergillus fumigatus chsC and chsG genes encode class III chitin synthases with different functions. Mol Microbiol 20: 667-679.
87. Montenegro G, Sanchez Puch S, Jewtuchowicz VM, Pinoni MV, Relloso S, Temporitti E, Iovannitti CA, Mujica MT. 2009. Phenotypic and genotypic characterization of As-pergillus lentulus and Aspergillus fumigatus isolates in a patient with probable invasive aspergillosis. J Med Microbiol 58: 391-395.
88. Moore MM. 2013. The crucial role of iron uptake in Asper-gillus fumigatus virulence. Curr Opin Microbiol 16: 692-699.
89. Moreno MA, Ibrahim-Granet O, Vicentefranqueira R, Amich J, Ave P, Leal F, Latgé JP, Calera JA. 2007. The regulation of zinc homeostasis by the ZafA transcription-al activator is essential for Aspergillus fumigatus viru-lence. Mol Microbiol 64: 1182-1197.
90. Mouyna I, Morelle W, Vai M, Monod M, Lechenne B, Fon-taine T, Beauvais A, Sarfati J, Prevost MC, Henry C, et al. 2005. Deletion of GEL2 encoding for a b(1-3)glucanosyl-transferase affects morphogenesis and virulence in Asper-gillus fumigatus. Mol Microbiol 56: 1675-1688.
91. Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A, et al. 1995. Plasma (1!3)-b-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 345: 17-20.
92. O’Gorman CM, Fuller HT, Dyer PS. 2009. Discovery of a sexual cycle in the opportunistic fungal pathogen Asper-gillus fumigatus. Nature 457: 471-474.
93. Okamoto T, Tanida T, Wei B, Ueta E, Yamamoto T, Osaki T. 2004. Regulation of fungal infection by a combination of amphotericin B and peptide 2, a lactoferrin peptide that activates neutrophils. Clin Diagn Lab Immunol 11: 1111-1119.
94. Padhye AA, Godfrey JH, Chandler FW, Peterson SW. 1994. Osteomyelitis caused by Neosartorya pseudofischeri. J Clin Microbiol 32: 2832-2836.
95. Pagano L, Caira M, Candoni A, Offidani M, Martino B, Specchia G, Pastore D, Stanzani M, Cattaneo C, Fanci R, et al. 2010. Invasive aspergillosis in patients with acute myeloid leukemia: A SEIFEM-2008 registry study. Haematologica 95: 644-650.
96. Panepinto JC, Oliver BG, Fortwendel JR, Smith DL, Askew DS, Rhodes JC. 2003. Deletion of the Aspergillus fumiga-tus gene encoding the Ras-related protein RhbA reduces virulence in a model of invasive pulmonary aspergillosis. Infect Immun 71: 2819-2826.
97. Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, et al. 2010. Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associat-ed Infection Surveillance Network (TRANSNET). Clin Infect Dis 50: 1101-1111.
98. Paris S, Wysong D, Debeaupuis JP, Shibuya K, Philippe B, Diamond RD, Latgé JP. 2003. Catalases of Aspergillus fumigatus. Infect Immun 71: 3551-3562.
99. Pelaez T, Alvarez-Perez S, Mellado E, Serrano D, Valerio M, Blanco JL, Garcia ME, Munoz P, Cuenca-Estrella M, Bouza E. 2013. Invasive aspergillosis caused by cryptic Aspergillus species: A report of two consecutive episodes in a patient with leukaemia. J Med Microbiol 62: 474-478.
100. Perfect JR, Cox GM, Lee JY, Kauffman CA, de Repentigny L, Chapman SW, Morrison VA, Pappas P, Hiemenz JW, Ste-vens DA, Mycoses Study Group. 2001. The impact of culture isolation of Aspergillus species: A hospital-based survey of aspergillosis. Clin Infect Dis 33: 1824-1833.
101. Peterson SW. 2008. Phylogenetic analysis of Aspergillus spe-cies using DNA sequences from four loci. Mycologia 100: 205-226.
102. Pfeiffer CD, Fine JP, Safdar N. 2006. Diagnosis of invasive aspergillosis using a galactomannan assay: A meta-anal-ysis. Clin Infect Dis 42: 1417-1427.
103. Posteraro B, Mattei R, Trivella F, Maffei A, Torre A, De Ca-rolis E, Posteraro P, Fadda G, Sanguinetti M. 2011. Un-common Neosartorya udagawae fungus as a causative agent of severe corneal infection. J Clin Microbiol 49: 2357-2360.
104. Rankin NE. 1953. Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy. Brit Med J 183: 918-919.
105. Raper KB, Fennell DI. 1965. The genus Aspergillus. Williams & Wilkins, Baltimore.
106. Reeves EP, Reiber K, Neville C, Scheibner O, Kavanagh K, Doyle S. 2006. A nonribosomal peptide synthetase (Pes1) confers protection against oxidative stress in Aspergillus fumigatus. FEBS J 273: 3038-3053.
107. Richardson MD. 2005. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 56: i5-i11.
108. Romano J, Nimrod G, Ben-Tal N, Shadkchan Y, Baruch K, Sharon H, Osherov N. 2006. Disruption of the Aspergillus fumigatus ECM33 homologue results in rapid conidial germination, antifungal resistance and hypervirulence. Microbiology 152: 1919-1928.
109. Sales-Campos H, Tonani L, Cardoso CR, Kress MR. 2013. The immune interplay between the host and the patho-gen in Aspergillus fumigatus lung infection. Biomed Res Int 2013: 693023.
110. Samson RA, Hong S, Peterson SW, Frisvad JC, Varga J. 2007. Polyphasic taxonomy of Aspergillus section Fumigati and its teleomorph Neosartorya. Stud Mycol 59: 147-203.
111. Saugier-Veber P, Devergie A, Sulahian A, Ribaud P, Traore F, Bourdeau-Esperou H, Gluckman E, Derouin F. 1993. Ep-idemiology and diagnosis of invasive pulmonary asper-gillosis in bone marrow transplant patients: Results of a 5 year retrospective study. Bone Marrow Transplant 12: 121-124.
112. Schell WA. 1995. New aspects of emerging fungal pathogens. A multifaceted challenge. Clin Lab Med 15: 365-387.
113. Schmalhorst PS, Krappmann S, Vervecken W, Rohde M, Muller M, Braus GH, Contreras R, Braun A, Bakker H, Routier FH. 2008. Contribution of galactofuranose to the virulence of the opportunistic pathogen Aspergillus fumi-gatus. Eukaryot Cell 7: 1268-1277.
114. Schmitt I, Crespo A, Divakar PK, Fankhauser JD, Herman-Sackett E, Kalb K, Nelsen MP, Nelson NA, Rivas-Plata E, Shimp AD, et al. 2009. New primers for promising single-copy genes in fungal phylogenetics and systematics. Per-soonia 23: 35-40.
115. Schrettl M, Bignell E, Kragl C, Joechl C, Rogers T, Arst HN Jr, Haynes K, Haas H. 2004. Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence. J Exp Med 200: 1213-1219.
116. Schrettl M, Bignell E, Kragl C, Sabiha Y, Loss O, Eisendle M, Wallner A, Arst HN Jr, Haynes K, Haas H. 2007. Distinct roles for intra-and extracellular siderophores during As-pergillus fumigatus infection. PLoS Pathog 3: e128.
117. Segal BH, DeCarlo ES, Kwon-Chung KJ, Malech HL, Gallin JI, Holland SM. 1998. Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) 77: 345-354.
118. Shivaprakash MR, Jain N, Gupta S, Baghela A, Gupta A, Chakrabarti A. 2009. Allergic fungal rhinosinusitis caused by Neosartorya hiratsukae from India. Med Mycol 47: 317-320.
119. Singh PK, Kathuria S, Agarwal K, Gaur SN, Meis JF, Chowdhary A. 2013. Clinical ignificance and molecular characterization of non-sporulating moulds isolated from the respiratory tract of bronchopulmonary mycoses patients with special reference to basidiomycetes. J Clin Microbiol 51: 3331-3337.
120. Soriani FM, Malavazi I, da Silva Ferreira ME, Savoldi M, Von Zeska Kress MR, de Souza Goldman MH, Loss O, Bignell E, Goldman GH. 2008. Functional characterization of the Aspergillus fumigatus CRZ1 homologue, CrzA. Mol Mi-crobiol 67: 1274-1291.
121. Spikes S, Xu R, Nguyen CK, Chamilos G, Kontoyiannis DP, Jacobson RH, Ejzykowicz DE, Chiang LY, Filler SG, May GS. 2008. Gliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence. J In-fect Dis 197: 479-486.
122. Steinbach WJ, Cramer RA Jr, Perfect BZ, Asfaw YG, Sauer TC, Najvar LK, Kirkpatrick WR, Patterson TF, Benjamin DK Jr, Heitman J, et al. 2006. Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryot Cell 5: 1091-1103.
123. Steinbach WJ, Reedy JL, Cramer RA Jr, Perfect JR, Heitman J. 2007. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Micro-biol 5: 418-430.
124. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, Bamberger DM, Weinmann AJ, Tuazon CU, Judson MA, et al. 2000. A randomized trial of itracona-zole in allergic bronchopulmonary aspergillosis. N Engl J Med 342: 756-762.
125. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, Denning DW, Crameri R, Brody AS, Light M, et al. 2003. Allergic bronchopulmonary aspergillosis in cystic fibrosis—State of the art: Cystic Fibrosis Foun-dation Consensus Conference. Clin Infect Dis 37: S225-S264.
126. Stynen D, Goris A, Sarfati J, Latgé JP. 1995. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 33: 497-500.
127. Sugui JA, Pardo J, Chang YC, Zarember KA, Nardone G, Galvez EM, Mullbacher A, Gallin JI, Simon MM, Kwon-Chung KJ. 2007. Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates viru-lence in mice immunosuppressed with hydrocortisone. Eukaryot Cell 6: 1562-1569.
128. Sugui JA, Vinh DC, Nardone G, Shea YR, Chang YC, Ze-lazny AM, Marr KA, Holland SM, Kwon-Chung KJ. 2010. Neosartorya udagawae (Aspergillus udagawae), an emerg-ing agent of aspergillosis: How different is it from Asper-gillus fumigatus? J Clin Microbiol 48: 220-228.
129. Summerbell RC, de Repentigny L, Chartrand C, St Germain G. 1992. Graft-related endocarditis caused by Neosar-torya fischeri var. spinosa. J Clin Microbiol 30: 1580-1582.
130. Svirshchevskaya E, Zubkov D, Mouyna I, Berkova N. 2012. Innate immunity and the role of epithelial barrier during Aspergillus fumigatus infection. Curr Immunol Rev 8: 254-261.
131. Swilaiman SS, O’Gorman CM, Balajee SA, Dyer PS. 2013. Discovery of a sexual cycle in Aspergillus lentulus, a close relative of A. fumigatus. Eukaryot Cell 12: 962-969.
132. Symoens F, Haase G, Pihet M, Carrere J, Beguin H, Degand N, Mely L, Bouchara JP. 2010. Unusual Aspergillus species in patients with cystic fibrosis. Med Mycol 48: S10-S16.
133. Tekaia F, Latgé JP. 2005. Aspergillus fumigatus: Saprophyte or pathogen? Curr Opin Microbiol 8: 385-392.
134. Thom C, Church MB. 1918. Aspergillus fumigatus, A nidulans, A terreus N Sp and their allies. Am J Bot 5: 84-104.
135. Thom C, Church MB. 1926. The Aspergili. Williams & Wil-kins, Baltimore. Tomee JF, van der Werf TS. 2001. Pulmonary aspergillosis. Neth J Med 59: 244-258.
136. Toskova M, Palousova D, Kocmanova I, Pavlovsky Z, Timil-sina S, Lengerova M, Mayer J, Racil Z. 2013. Invasive mould disease involving the gastrointestinal tract caused by Neosartorya pseudofischeri in a haematological patient. Mycoses 56: 385-388.
137. Tsai HF, Chang YC, Washburn RG, Wheeler MH, Kwon-Chung KJ. 1998. The developmentally regulated alb1 gene of Aspergillus fumigatus: Its role in modulation of conidial morphology and virulence. J Bacteriol 180: 3031-3038.
138. Tsitsigiannis DI, Bok JW, Andes D, Nielsen KF, Frisvad JC, Keller NP. 2005. Aspergillus cyclooxygenase-like enzymes are associated with prostaglandin production and viru-lence. Infect Immun 73: 4548-4559.
139. Urban CF, Reichard U, Brinkmann V, Zychlinsky A. 2006. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol 8: 668-676.
140. Vinh DC, Shea YR, Jones PA, Freeman AF, Zelazny A, Hol-land SM. 2009a. Chronic invasive aspergillosis caused by Aspergillus viridinutans. Emerg Infect Dis 15: 1292-1294.
141. Vinh DC, Shea YR, Sugui JA, Parrilla-Castellar ER, Freeman AF, Campbell JW, Pittaluga S, Jones PA, Zelazny A, Kleiner D, et al. 2009b. Invasive aspergillosis due to Neo-sartorya udagawae. Clin Infect Dis 49: 102-111.
142. Virchow R. 1856. Beitrage zur Lehere von den beim Men-schen vorkommenden pflanzlichen Parasiten. Arch Pathol Anat Physiol Klin Med 9: 557-593.
143. Wagener J, Echtenacher B, Rohde M, Kotz A, Krappmann S, Heesemann J, Ebel F. 2008. The putative a-1,2-manno-syltransferase AfMnt1 of the opportunistic fungal path-ogen Aspergillus fumigatus is required for cell wall stabil-ity and full virulence. Eukaryot Cell 7: 1661-1673.
144. Wald A, Leisenring W, van Burik JA, Bowden RA. 1997. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 175: 1459-1466.
145. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kon-toyiannis DP, Marr KA, Morrison VA, Segal BH, Stein-bach WJ, Stevens DA, et al. 2008. Treatment of aspergil-losis: Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46: 327-360.
146. White TJ, Bruns T, Lee S, Taylor JW. 1990. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In PCR protocols: A guide to methods and applications (ed. Innis MA, Gelfand DH, Sninsky JJ, White TJ), pp. 315-322. Academic, New York.
147. Willger SD, Puttikamonkul S, Kim KH, Burritt JB, Grahl N, Metzler LJ, Barbuch R, Bard M, Lawrence CB, Cramer RA Jr 2008. A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus. PLoS Pathog 4: e1000200.
148. Yaguchi T, Horie Y, Tanaka R, Matsuzawa T, Ito J, Nishimura K. 2007. Molecular phylogenetics of multiple genes on Aspergillus section Fumigati isolated from clinical speci-mens in Japan. Nippon Ishinkin Gakkai Zasshi 48: 37-46.
149. Zbinden A, Imhof A, Wilhelm MJ, Ruschitzka F, Wild P, Bloemberg GV, Mueller NJ. 2012. Fatal outcome after heart transplantation caused by Aspergillus lentulus. Transpl Infect Dis 14: E60-E63
150. Zhao W, Panepinto JC, Fortwendel JR, Fox L, Oliver BG, Askew DS, Rhodes JC. 2006. Deletion of the regulatory subunit of protein kinase A in Aspergillus fumigatus alters morphology, sensitivity to oxidative damage, and viru-lence. Infect Immun 74: 4865-4874.